Cargando…
A new role for statins in sepsis
Several studies have shown promising results regarding the use of statins as an adjunctive treatment for sepsis. Most of those studies were retrospective or observational in nature. The ASEPSIS trial has reported that the administration of atorvastatin reduced clinical progression of sepsis but did...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056163/ https://www.ncbi.nlm.nih.gov/pubmed/23324213 http://dx.doi.org/10.1186/cc11907 |
_version_ | 1782320798529224704 |
---|---|
author | Rachoin, Jean-Sebastien Cerceo, Elizabeth Dellinger, R Phillip |
author_facet | Rachoin, Jean-Sebastien Cerceo, Elizabeth Dellinger, R Phillip |
author_sort | Rachoin, Jean-Sebastien |
collection | PubMed |
description | Several studies have shown promising results regarding the use of statins as an adjunctive treatment for sepsis. Most of those studies were retrospective or observational in nature. The ASEPSIS trial has reported that the administration of atorvastatin reduced clinical progression of sepsis but did not improve mortality. These findings are promising and further multicenter trials are needed to confirm these outcomes and to establish whether this class of medications will offer utility in this regard. |
format | Online Article Text |
id | pubmed-4056163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40561632014-06-14 A new role for statins in sepsis Rachoin, Jean-Sebastien Cerceo, Elizabeth Dellinger, R Phillip Crit Care Commentary Several studies have shown promising results regarding the use of statins as an adjunctive treatment for sepsis. Most of those studies were retrospective or observational in nature. The ASEPSIS trial has reported that the administration of atorvastatin reduced clinical progression of sepsis but did not improve mortality. These findings are promising and further multicenter trials are needed to confirm these outcomes and to establish whether this class of medications will offer utility in this regard. BioMed Central 2013 2013-01-17 /pmc/articles/PMC4056163/ /pubmed/23324213 http://dx.doi.org/10.1186/cc11907 Text en Copyright © 2013 BioMed Central Ltd |
spellingShingle | Commentary Rachoin, Jean-Sebastien Cerceo, Elizabeth Dellinger, R Phillip A new role for statins in sepsis |
title | A new role for statins in sepsis |
title_full | A new role for statins in sepsis |
title_fullStr | A new role for statins in sepsis |
title_full_unstemmed | A new role for statins in sepsis |
title_short | A new role for statins in sepsis |
title_sort | new role for statins in sepsis |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056163/ https://www.ncbi.nlm.nih.gov/pubmed/23324213 http://dx.doi.org/10.1186/cc11907 |
work_keys_str_mv | AT rachoinjeansebastien anewroleforstatinsinsepsis AT cerceoelizabeth anewroleforstatinsinsepsis AT dellingerrphillip anewroleforstatinsinsepsis AT rachoinjeansebastien newroleforstatinsinsepsis AT cerceoelizabeth newroleforstatinsinsepsis AT dellingerrphillip newroleforstatinsinsepsis |